#antibiotic-resistance

#antibiotic-resistance

Rising cases of invasive group A strep infections in the U.S. indicate increasing health risks and antibiotic resistance.

Researchers are exploring non-antibiotic methods to prevent recurrent UTIs, including vaccines and non-antibiotic drugs.

Microplastics significantly enhance antibiotic resistance in E. coli, posing severe public health risks.

Phage therapy demonstrates potential as a solution to antibiotic resistance in bacterial infections.

Superbugs like MRSA pose significant global health risks due to rising antibiotic resistance, leading to over a million deaths annually.

Microbes may travel long distances on high-level winds, highlighting the risk of antibiotic resistance spreading across regions.

Abstaining from sex is the only way to completely avoid STIs, as antibiotics are becoming increasingly ineffective against infections like gonorrhea.

A new molecule, lariocidin, discovered from soil samples shows promise in treating antibiotic-resistant e. coli infections.

Phage therapy, once overlooked, is regaining interest in combating antibiotic-resistant bacterial infections.

Alan Hauser, MD, PhD, awarded the 2024 Tripartite Legacy Faculty Prize for excellence in research and education in microbiology and immunology.

Phage therapy is emerging as a viable treatment against antibiotic-resistant bacteria due to increasing resistance and the need for alternative therapies.

Dogs like Jodie may help detect infections and antibiotic resistance through scent identification.

Locus's phage therapy effectively targets and degrades E. coli bacteria, showing promising results in treating urinary tract infections (UTIs).

Antibiotic persistence allows bacterial survival under stress, complicating treatment strategies.

The Longitude Prize has been awarded for a rapid infection test to combat superbugs.

The fight against superbugs involves delaying antibiotic resistance by using treatments judiciously and investing in prevention measures and new vaccines.